查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1918284

全球白色生物技术市场－2026-2031年预测

Global White Biotech Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球白色生物技术市场预计将从 2025 年的 3,347.55 亿美元成长到 2031 年的 5,410.97 亿美元，复合年增长率为 8.33%。

白色生物技术市场是一个涵盖工业生物技术的领域，其特点是利用微生物、植物细胞和酵素等活细胞来创造永续的产品和製程。该领域被视为现代生物经济的基础，为生质燃料、生质塑胶、药品、精细化学品和工业酶等多个工业领域提供环境友善替代方案，以取代传统的石油化工生产方式。

推动市场扩张的关键因素是全球减少碳排放和降低环境影响的迫切需求。随着各产业和政府加强应对气候变化，白色生物技术为脱碳提供了一条重要途径。与传统製造方法相比，该製程通常能耗更低、产生的废弃物更少，并且生产可生物降解的最终产品。这种与永续性目标的根本契合，使得生物基解决方案作为石化燃料衍生材料的可行替代方案，需求强劲，从而使白色生物技术成为工业转型的关键技术。

同时，强而有力的政府支持和策略性政策倡议正在加速全球市场发展。各国政府和区域政府日益认识到培育强大的生物经济的战略重要性。透过直接投资、研究津贴和支持性法规结构，公共正积极促进创新风险规避和生物基製造能力的扩张。这种自上而下的支持对于建立必要的基础设施和刺激整个价值链上的私人投资至关重要。

基因工程和製程优化领域的持续创新推动了技术进步，为该领域的发展奠定了基础。精准改造微生物以提高其效率、产量和新型化合物的生产能力是关键驱动力。基因工程的进步，以及发酵技术和生物催化剂设计的改进，不断扩展白色生物技术的应用范围和商业性可行性。这些创新降低了生产成本，并使生产更复杂、高附加价值的产品成为可能。

从区域角度来看，亚太市场正崛起为一个主导性的高成长区域。这一成长轨迹得益于庞大且不断增长的人口、快速的工业化以及政府积极推行的永续政策。该地区各国正在实施旨在提升国内生物技术能力、减少对进口化石燃料的依赖以及应对紧迫环境挑战的各项措施。该地区大规模的製造业基础以及对循环经济原则日益增长的重视，为工业生物技术解决方案的采纳和推广提供了沃土。

白色生物技术在多个战略产业的广泛应用，充分证明了其经济重要性和韧性。白色生物技术的应用范围并不局限于单一领域，而是在能源（生质燃料）、材料（生质塑胶）、健康（药品和酵素）以及农业等领域的变革中发挥着至关重要的作用。这种多样性降低了风险，并确保成长能够顺应跨产业永续性和供应链安全的趋势。该技术在开发现有产品的兼容替代品和全新材料方面的作用，巩固了其作为多功能工业平台的地位。

总之，白色生物技术市场的发展受到环境需求、政策支持和科学创新三者强强联合的驱动。全球对减少碳排放的迫切关注构成了强劲的长期需求驱动力，而政府的生物经济战略也为其发展注入了关键动力。基因工程和製程工程的持续进步正在拓展技术和商业性可行性领域。亚太地区凭藉其庞大的人口和经济规模，可望实现显着成长。白色生物技术市场策略性地位于工业生产力和生态学永续性的交汇点，预计将继续融入全球製造业格局。

本报告的主要优势：

  • 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略实现市场渗透的潜力。
  • 市场驱动因素与未来趋势：探索推动市场的动态因素和关键趋势，以及它们将如何塑造未来的市场发展。
  • 可操作的建议：利用这些见解，在快速变化的环境中製定策略决策，发展新的商业机会和收入来源。
  • 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

企业使用我们的报告的目的是什么？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区（包括国家）分類的收入和预测评估
  • 公司概况（策略、产品、财务资讯）及主要发展动态。

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 全球白色生物技术市场（依微生物类型划分）

  • 介绍
  • 酵母菌
  • 细菌
  • 其他的

6. 全球白色生物技术市场（按应用划分）

  • 介绍
  • 生质燃料
  • 生质塑胶
  • 生化产品
  • 其他的

7. 全球白色生物技术市场（以最终用户划分）

  • 介绍
  • 化学品
  • 食品/饮料
  • 电力和能源
  • 其他的

8. 全球白色生物技术市场（按地区划分）

  • 介绍
  • 北美洲
    • 依微生物类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依微生物类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 依微生物类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 德国
      • 法国
      • 英国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 依微生物类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 依微生物类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 印尼
      • 泰国
      • 其他的

第九章：竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • Cargill Incorporated
  • DuPont
  • DSM-Firmenich
  • BASF SE
  • Evonik Industries AG
  • Laurus Labs
  • Corbion NV
  • Novonesis
  • ADM
  • Lonza Group Ltd

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061616284

Global White Biotech Market, with a 8.33% CAGR, is forecasted to grow from USD 334.755 billion in 2025 to USD 541.097 billion in 2031.

The white biotechnology market, encompassing industrial biotechnology, is defined by the application of living cells-such as microorganisms, plant cells, and enzymes-to create sustainable products and processes. This sector stands as a cornerstone of the modern bioeconomy, offering environmentally favorable alternatives to conventional petrochemical-based production across a diverse range of industries including biofuels, bioplastics, pharmaceuticals, fine chemicals, and industrial enzymes.

A paramount driver for market expansion is the global imperative to reduce carbon emissions and environmental impact. As industries and governments intensify efforts to mitigate climate change, white biotech provides a critical pathway for decarbonization. Its processes typically consume less energy, generate reduced waste, and yield biodegradable end-products compared to traditional manufacturing. This fundamental alignment with sustainability goals is creating robust demand for bio-based solutions as viable replacements for fossil fuel-derived materials, positioning white biotech as an essential technology for industrial transformation.

Concurrently, significant governmental support and strategic policy initiatives are accelerating market development worldwide. National and regional governments are increasingly recognizing the strategic importance of fostering a strong bioeconomy. Through direct investments, research grants, and supportive regulatory frameworks, public policy is actively de-risking innovation and scaling up bio-based manufacturing capacities. This top-down support is crucial for building the necessary infrastructure and stimulating private sector investment across the value chain.

Technological advancement forms the bedrock of the sector's progress, with continuous innovation in genetic engineering and process optimization. The ability to precisely modify microorganisms-enhancing their efficiency, yield, and ability to produce novel compounds-is a key enabler. Advances in genetic modification techniques, alongside improvements in fermentation technology and biocatalyst design, are continually expanding the commercial feasibility and scope of white biotech applications. These innovations are lowering production costs and enabling the manufacture of more complex, high-value products.

From a regional perspective, the Asia Pacific market is emerging as a dominant and high-growth area. This trajectory is fueled by a combination of large, expanding populations, rapid industrialization, and proactive government policies aimed at promoting sustainable development. Nations within the region are implementing initiatives to build domestic biotech capabilities, reduce reliance on imported fossil resources, and address pressing environmental challenges. The region's substantial manufacturing base and growing focus on circular economy principles provide a fertile ground for the adoption and scaling of industrial biotechnology solutions.

The market's broad application across multiple strategic industries underscores its economic significance and resilience. White biotech is not confined to a single sector but is integral to transformative shifts in energy (biofuels), materials (bioplastics), health (pharmaceuticals and enzymes), and agriculture. This diversification mitigates risk and ensures that growth is fueled by cross-industrial trends toward sustainability and supply chain security. The technology's role in creating drop-in replacements as well as entirely novel materials solidifies its position as a versatile industrial platform.

In conclusion, the white biotechnology market is being propelled by a powerful convergence of environmental necessity, policy support, and scientific innovation. The urgent global focus on reducing carbon footprints provides a compelling, long-term demand driver, while governmental bioeconomy strategies are providing essential momentum. Continuous advancements in genetic and process engineering are expanding the technical and commercial horizons of what is possible. With the Asia Pacific region poised for substantial growth due to its demographic and economic scale, the white biotech market is strategically positioned at the intersection of industrial productivity and ecological sustainability, poised for continued integration into the global manufacturing landscape.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

White Biotech Market Segmentation

  • By Microorganism Type
  • Yeast
  • Bacteria
  • Others
  • By Application
  • Biofuels
  • Bioplastic
  • Biochemicals
  • Others
  • By End-User
  • Chemicals
  • Food & Beverage
  • Power & Energy
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. WHITE BIOTECH MARKET BY MICROGRANISM TYPE

  • 5.1. Introduction
  • 5.2. Yeast
  • 5.3. Bacteria
  • 5.4. Others

6. WHITE BIOTECH MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Biofuels
  • 6.3. Bioplastic
  • 6.4. Biochemicals
  • 6.5. Others

7. WHITE BIOTECH MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Chemicals
  • 7.3. Food & Beverage
  • 7.4. Power & Energy
  • 7.5. Others

8. WHITE BIOTECH MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Microorganism Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Microorganism Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Microorganism Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Microorganism Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Microorganism Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. India
      • 8.6.4.3. Japan
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Cargill Incorporated
  • 10.2. DuPont
  • 10.3. DSM-Firmenich
  • 10.4. BASF SE
  • 10.5. Evonik Industries AG
  • 10.6. Laurus Labs
  • 10.7. Corbion NV
  • 10.8. Novonesis
  • 10.9. ADM
  • 10.10. Lonza Group Ltd

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations